On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
TuesdayMar 21, 2023 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Tracking Proprietary Path to Drug Delivery Innovation and Commercialization on Robust R&D Programs

Lexaria Bioscience is a global innovator in drug delivery platforms The company has been developing and commercializing patented DehydraTECH(TM), a technology that has been shown to increase the bioavailability of fat-soluble active molecules, improve the speed of onset and provide other benefits across multiple applications Lexaria has undertaken numerous R&D programs in an effort to build relationships with prospective corporate partners to out-license the technology or to form other profitable corporate relationships The company owes its achievements to its focus on R&D and the guidance provided by its highly experienced leadership, including CEO Chris Bunka, President John Docherty, as well…

Continue Reading

TuesdayMar 21, 2023 9:00 am

India Globalization Capital Inc. (NYSE American: IGC) Reports Triple-Digit Revenue Growth, Phase 2 Study Highlights in Q3 2023 Report

Net revenue increased 133% to $332,000 in the three months ended Dec. 31, 2022, the company reports Corporate highlights included expanded trial sites, enrollment for phase 2 IGC-AD1 study Commencement of study marks milestone in IGC’s progress toward gaining FDA approval for proprietary treatment In a fragile economic environment, the third-quarter 2023 financial results reported by India Globalization Capital (NYSE American: IGC) are particularly remarkable. The company, which is pursuing effective treatment for Alzheimer’s patients suffering with agitation and other neuropsychiatric symptoms, released a report showing an increase in net revenue of 133% for the three-month period ending Dec. 31,…

Continue Reading

TuesdayMar 21, 2023 4:20 am

420 with CNW — Adult-Use Cannabis Demand Exceeds Projections in Missouri

Since Missouri dispensaries started selling marijuana for recreational purposes more than a month ago, demand has outpaced expectations. In November 2022, a measure allowing for recreational cannabis sales was approved, opening the door for the establishment of dispensaries in the state. Marijuana sales reached $102.9 million in February, with recreational sales accounting for $71.7 million of the total. The first weekend of sales brought in $13 million. In addition to experiencing astronomical sales and customer numbers in its first month, Missouri has seen a nearly 50% increase in the wholesale price of marijuana flower. According to LeafLink — a wholesale…

Continue Reading

MondayMar 20, 2023 4:20 pm

420 with CNW — Florida House Committee Approves Bill Allowing Telehealth Medical Cannabis Certification

A Florida House Committee has unanimously approved a measure that would allow the use of telehealth in certain aspects of cannabis treatment. Bill HB 387 would make it possible for doctors to use telehealth to renew their patients’ medical cannabis approvals. According to sponsor Rep Spencer Roach, the bill would treat medical cannabis like any other pharmaceutical. Venice-based physician Dr. Barry Gordon told the House Health Care Regulation Subcommittee before the vote that leveraging telehealth to renew medical cannabis certifications would benefit the most vulnerable Floridians. As dozens of states have legalized marijuana for medical use, millions of people across…

Continue Reading

MondayMar 20, 2023 4:20 am

420 with CNW — Bill Targeting Illicit Marijuana Grows Designed to Safeguard Users from Pesticides

A bipartisan pair of congressional lawmakers has refiled a draft law meant to address the growing problem of illicit cannabis plantations on federal land. The lawmakers framed the legislation as a much-needed tool for the government to rein in illegal cannabis grows that are polluting the environment and risking marijuana consumers’ health. Although dozens of states have launched medical and recreational cannabis markets, America’s illicit cannabis market is still thriving. Licensed sellers struggle to compete with the illicit market as high taxes, and rigid rules have made legal cannabis several times more expensive than black-market marijuana. As a result, the…

Continue Reading

FridayMar 17, 2023 4:20 pm

420 with CNW — Congressional Lawmakers Want Cannabis Scheduling Review More Transparent

On March 9, 2023, a group of nonpartisan Congress legislators penned a letter to senior Biden administration figures asking for transparency on the president's ongoing review of marijuana's legalization. A draft of the letter was recently distributed by Rep. Earl Blumenauer (D-OR) among Congress for signatures before being sent to Xavier Becerra, secretary of Health and Human Services (HHS), and Merrick Garland, United States attorney general. According to the letter’s content, Biden's scheduling directive presents a chance to evaluate the causes and effects of federal law in an open-minded manner. It also states that cannabis scheduling was based on prejudice…

Continue Reading

FridayMar 17, 2023 4:20 am

420 with CNW — Bipartisan Legislators File Bill Allowing Those with Drug Convictions Access to Hemp Industry

Bipartisan congressional legislators have filed a new measure to end the "discriminatory" federal rule that prevents people with prior felonies for drug offenses from owning or operating legal hemp businesses. The "Free to Grow Act," sponsored by Representatives Chellie Pingree (D-ME), David Trone (D-MD), Nancy Mace (R-SC) and Dave Joyce (R-OH), focuses only on the section of the 2018 Farm Bill that dealt with prior convictions and federal legalized hemp. Pingree stated that in spite of legalization, the industry's expansion is being hampered by bureaucracy, regulatory uncertainty and discriminatory policy. Congress is expected to approve a new farm bill version…

Continue Reading

ThursdayMar 16, 2023 4:20 pm

420 with CNW — DOJ Appeals Federal Ruling on Gun Rights for Marijuana Users

The U.S. Department of Justice is appealing a recent ruling by Federal Judge Patrick Wyrick that deemed it unconstitutional to prevent people who use state-legal marijuana from using guns. The Justice Department revealed in a filing to the Western District of Oklahoma U.S. District Court that it would appeal the ruling at the U.S. Court of Appeals for the Tenth Circuit. The appeal announcement by the U.S. government comes just a month after Wyrick’s landmark ruling. Although the two-page filing doesn’t elaborate on the arguments behind the ban, U.S. Attorney Robert Troester and Assistant U.S. Attorney David McCray will flesh…

Continue Reading

ThursdayMar 16, 2023 4:20 am

420 with CNW — Cannabis Advocates Pin Hopes on Delaware, Hawaii After Ballot Defeat in Oklahoma

Oklahoma voters recently rejected a measure that would have legalized recreational cannabis in the state and expanded access to adults aged 21 and older. With this decision, Oklahoma joined a group of conservative states that have recently rejected measures to legalize adult-use cannabis, including North Dakota, Arkansas and South Dakota. The recreational marijuana measure’s failure to pass in Oklahoma was a blow to advocates, who were hoping that changing attitudes among younger voters coupled with laissez-faire economic attitudes would swing the vote in favor of cannabis. Even though 10% of Oklahomans currently hold a medical cannabis card, 63% of voters…

Continue Reading

WednesdayMar 15, 2023 4:20 pm

420 with CNW — Pharmacologist Highlights Untapped Potential in Several Cannabinoids

Medical cannabis dispensaries have a growing selection of products for anxiety, pain, sex and other conditions, with many available strains having magical and evocative names such as Bubba Kush, Blue Dream and Chocolope. But what exactly does this mean? Do the various strains' medical properties differ from one another? Or are the creative names merely marketing ploys? Cannabis is not just a source of cannabinoids, as several studies have shown. The plants is an especially abundant source of therapeutic substances that humans have not yet fully explored. But to fully utilize the plant’s potential, society must move past its prejudices…

Continue Reading

Official NewsWire Relationships

Alternative Products Expo Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition Cannexpo Marigold PR MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo Tether BudTender Tether BudTender Appreciation Week

CannabisNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722